LIVANOVA PLC (LIVN) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:LIVN • GB00BYMT0J19

66.56 USD
+1.53 (+2.35%)
At close: Feb 6, 2026
66.56 USD
0 (0%)
After Hours: 2/6/2026, 8:00:02 PM
Fundamental Rating

5

Taking everything into account, LIVN scores 5 out of 10 in our fundamental rating. LIVN was compared to 186 industry peers in the Health Care Equipment & Supplies industry. LIVN has an average financial health and profitability rating. LIVN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • LIVN had positive earnings in the past year.
  • LIVN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: LIVN reported negative net income in multiple years.
  • Of the past 5 years LIVN 4 years had a positive operating cash flow.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

  • LIVN has a Return On Assets of -8.48%. This is in the better half of the industry: LIVN outperforms 64.52% of its industry peers.
  • LIVN's Return On Equity of -18.76% is fine compared to the rest of the industry. LIVN outperforms 61.83% of its industry peers.
  • LIVN's Return On Invested Capital of 8.38% is amongst the best of the industry. LIVN outperforms 86.02% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LIVN is significantly below the industry average of 8.80%.
  • The last Return On Invested Capital (8.38%) for LIVN is above the 3 year average (3.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -8.48%
ROE -18.76%
ROIC 8.38%
ROA(3y)-0.17%
ROA(5y)-4.25%
ROE(3y)-0.33%
ROE(5y)-8.59%
ROIC(3y)3.45%
ROIC(5y)N/A
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • LIVN's Operating Margin of 15.01% is amongst the best of the industry. LIVN outperforms 83.33% of its industry peers.
  • In the last couple of years the Operating Margin of LIVN has grown nicely.
  • LIVN has a better Gross Margin (68.50%) than 75.27% of its industry peers.
  • LIVN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.01%
PM (TTM) N/A
GM 68.5%
OM growth 3Y41.74%
OM growth 5Y18.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LIVN is destroying value.
  • The number of shares outstanding for LIVN remains at a similar level compared to 1 year ago.
  • LIVN has more shares outstanding than it did 5 years ago.
  • LIVN has a worse debt/assets ratio than last year.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • LIVN has an Altman-Z score of 1.83. This is not the best score and indicates that LIVN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • LIVN has a Altman-Z score of 1.83. This is comparable to the rest of the industry: LIVN outperforms 57.53% of its industry peers.
  • LIVN has a debt to FCF ratio of 2.26. This is a good value and a sign of high solvency as LIVN would need 2.26 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.26, LIVN belongs to the top of the industry, outperforming 86.02% of the companies in the same industry.
  • A Debt/Equity ratio of 0.30 indicates that LIVN is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.30, LIVN is in line with its industry, outperforming 52.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.26
Altman-Z 1.83
ROIC/WACC0.97
WACC8.65%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • LIVN has a Current Ratio of 1.32. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.32, LIVN is doing worse than 76.88% of the companies in the same industry.
  • LIVN has a Quick Ratio of 1.12. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • LIVN's Quick ratio of 1.12 is on the low side compared to the rest of the industry. LIVN is outperformed by 72.04% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.12
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

  • LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
  • The Earnings Per Share has been growing slightly by 1.82% on average over the past years.
  • The Revenue has grown by 8.63% in the past year. This is quite good.
  • The Revenue has been growing slightly by 2.94% on average over the past years.
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.20% on average over the next years. This is quite good.
  • Based on estimates for the next years, LIVN will show a small growth in Revenue. The Revenue will grow by 7.67% on average per year.
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.47%
EPS Next 5Y13.2%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.95%
Revenue Next 5Y7.67%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.29 indicates a rather expensive valuation of LIVN.
  • Based on the Price/Earnings ratio, LIVN is valued cheaper than 87.63% of the companies in the same industry.
  • LIVN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 15.79, LIVN is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 89.25% of the companies listed in the same industry.
  • LIVN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.29
Fwd PE 15.79
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 84.41% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, LIVN is valued cheaper than 90.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.93
EV/EBITDA 13.86
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • LIVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of LIVN may justify a higher PE ratio.
PEG (NY)1.03
PEG (5Y)9.52
EPS Next 2Y11.85%
EPS Next 3Y10.47%

0

5. Dividend

5.1 Amount

  • No dividends for LIVN!.
Industry RankSector Rank
Dividend Yield 0%

LIVANOVA PLC

NASDAQ:LIVN (2/6/2026, 8:00:02 PM)

After market: 66.56 0 (0%)

66.56

+1.53 (+2.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners105.72%
Inst Owner Change-1.34%
Ins Owners0.28%
Ins Owner Change0.34%
Market Cap3.63B
Revenue(TTM)1.35B
Net Income(TTM)-217.00M
Analysts82.35
Price Target73.19 (9.96%)
Short Float %3.37%
Short Ratio3.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.36%
Min EPS beat(2)18.42%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)12.75%
Min EPS beat(4)-0.89%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)18.55%
EPS beat(12)11
Avg EPS beat(12)18.19%
EPS beat(16)14
Avg EPS beat(16)14.3%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.79%
Revenue beat(12)11
Avg Revenue beat(12)3.51%
Revenue beat(16)13
Avg Revenue beat(16)2.69%
PT rev (1m)3.41%
PT rev (3m)12.77%
EPS NQ rev (1m)0.65%
EPS NQ rev (3m)0.38%
EPS NY rev (1m)0.12%
EPS NY rev (3m)2.96%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.96%
Valuation
Industry RankSector Rank
PE 17.29
Fwd PE 15.79
P/S 2.69
P/FCF 18.93
P/OCF 14.48
P/B 3.14
P/tB 27.54
EV/EBITDA 13.86
EPS(TTM)3.85
EY5.78%
EPS(NY)4.22
Fwd EY6.33%
FCF(TTM)3.52
FCFY5.28%
OCF(TTM)4.6
OCFY6.91%
SpS24.7
BVpS21.2
TBVpS2.42
PEG (NY)1.03
PEG (5Y)9.52
Graham Number42.86
Profitability
Industry RankSector Rank
ROA -8.48%
ROE -18.76%
ROCE 11.71%
ROIC 8.38%
ROICexc 13.38%
ROICexgc 250.34%
OM 15.01%
PM (TTM) N/A
GM 68.5%
FCFM 14.23%
ROA(3y)-0.17%
ROA(5y)-4.25%
ROE(3y)-0.33%
ROE(5y)-8.59%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.41%
ROICexc growth 3Y38.4%
ROICexc growth 5Y24.59%
OM growth 3Y41.74%
OM growth 5Y18.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.26
Debt/EBITDA 1.41
Cap/Depr 132.77%
Cap/Sales 4.37%
Interest Coverage 250
Cash Conversion 101.63%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.12
Altman-Z 1.83
F-Score6
WACC8.65%
ROIC/WACC0.97
Cap/Depr(3y)78.92%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.47%
EPS Next 5Y13.2%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.95%
Revenue Next 5Y7.67%
EBIT growth 1Y51.48%
EBIT growth 3Y51.06%
EBIT growth 5Y22.44%
EBIT Next Year41.25%
EBIT Next 3Y18.09%
EBIT Next 5Y3.36%
FCF growth 1Y2168.7%
FCF growth 3Y20.84%
FCF growth 5YN/A
OCF growth 1Y532.9%
OCF growth 3Y21.3%
OCF growth 5YN/A

LIVANOVA PLC / LIVN FAQ

Can you provide the ChartMill fundamental rating for LIVANOVA PLC?

ChartMill assigns a fundamental rating of 5 / 10 to LIVN.


Can you provide the valuation status for LIVANOVA PLC?

ChartMill assigns a valuation rating of 6 / 10 to LIVANOVA PLC (LIVN). This can be considered as Fairly Valued.


What is the profitability of LIVN stock?

LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.


What is the financial health of LIVANOVA PLC (LIVN) stock?

The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.


Can you provide the expected EPS growth for LIVN stock?

The Earnings per Share (EPS) of LIVANOVA PLC (LIVN) is expected to grow by 16.86% in the next year.